Literature DB >> 4974382

Immunizing capacity of viable and killed attenuated mycobacterial cells against experimental tuberculous infection.

G P Youmans, A S Youmans.   

Abstract

The relationship of the dose of vaccine to the immune response was determined in CF-1 mice vaccinated intraperitoneally with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis and in mice vaccinated with cells of the same strain killed by autoclaving at 121 C for 15 min. The results showed, in terms of increased resistance to tuberculous infection, that the immune response with both living and killed cells was dependent upon the dose of vaccine, whereas only the living cells were dependent upon the time of challenge after vaccination. The dose response curves show dramatically that viable cells, which do not multiply in vivo, are several hundred times more effective immunizing agents against tuberculous infection than are autoclaved cells. Viable 2-week-old H37Ra cells were far more immunogenic than viable 4-week-old cells. Autoclaved 2-week-old cells, however, were no more immunogenic than autoclaved 4-week-old cells. H37Ra cells killed by boiling (98 C), exposure to 65 C for 30 min, treating with 2% phenol, or by being dried with acetone also lost most of their capacity to immunize mice. The effect of adjuvant on the immune response of mice to tuberculous infection was tested by incorporating both viable and autoclaved cells in Freund's incomplete adjuvant. We found that this vehicle had little or no effect on the immunizing capacity of either viable or heat-killed mycobacterial cells. The relationship of all the findings to the specificity of the immune response to tuberculosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4974382      PMCID: PMC249556          DOI: 10.1128/jb.97.1.107-113.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  27 in total

1.  Vaccination against tuberculosis with nonliving vaccines. I. The problem and its historical background.

Authors:  D W WEISS
Journal:  Am Rev Respir Dis       Date:  1959-09

2.  Vaccination against tuberculosis with nonliving vaccines. II. Vaccination of guinea pigs with phenol-killed tubercle bacilli.

Authors:  D W WEISS; A Q WELLS
Journal:  Am Rev Respir Dis       Date:  1960-04

3.  The effect of adjuvants on antituberculosis vaccination with live Mycobacteria.

Authors:  H BLOCH; I FERREIRA
Journal:  J Immunol       Date:  1959-10       Impact factor: 5.422

4.  Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

5.  Ribonucleic acid, deoxyribonucleic acid, and protein content of cells of different ages of Mycobacterium tuberculosis and the ralationship to immunogenicity.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

Review 6.  Nonliving immunogenic substances of Mycobacteria.

Authors:  D W Smith; A A Grover; E Wiegeshaus
Journal:  Bibl Tuberc       Date:  1968

7.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

8.  Nonspecific factors in resistance of mice to experimental tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1965-12       Impact factor: 3.490

9.  Bacterial populations in experimental murine tuberculosis. II. Studies in vaccinated mice.

Authors:  H BLOCH; Y YAMAMURA; A WALTER
Journal:  J Infect Dis       Date:  1960 Mar-Apr       Impact factor: 5.226

10.  Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.

Authors:  S Coppel; G P Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

View more
  4 in total

1.  Lung weight parallels disease severity in experimental coccidioidomycosis.

Authors:  M Huppert; S H Sun; I Gleason-Jordon; K R Vukovich
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

2.  Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.

Authors:  A S Youmans; G P Youmans; D Cahall
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

3.  Mechanism of tuberculostasis in mammalian serum. II. Induction of serum tuberculostasis in guinea pigs.

Authors:  I Kochan; C A Golden; J A Bukovic
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

4.  Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.

Authors:  S Coppel; G P Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.